Background-Complement system, an innate immunity, has been well documented to play a critical role in many inflammatory diseases. However, the role of complement in the pathogenesis of abdominal aortic aneurysm, which is considered an immune and inflammatory disease, remains obscure.
chronic aortic wall inflammation and destructive connective tissue remodeling, including depletion of aortic elastin and fragmentation of medial elastic fibers. AAA is a leading cause of sudden death in aging (Ͼ55 years) men. 1 Rupture of AAA accounts for 4% of all deaths in people Ͼ65 years of age. Risk factors for AAA include age, male gender, atherosclerosis, hypertension, and genetic predisposition, although atherosclerosis is considered to be a main cause of AAA. 2 Enzymatic degradation of elastic lamellae and extracellular matrix proteins are underlying characteristics of AAA. 3 It is well established that abnormally increased protease activity in aortic tissue plays a critical role in the pathogenesis of aortic dissection and aneurysm. Matrix metalloproteinases (MMPs) such as MMP2 and MMP9 are the predominant proteinases in AAA wall. 2 In animal models, the development of aneurysms can be suppressed by pharmaco-logical inhibition (ie, by tetracycline derivatives) of MMP2 and MMP9 or by genetic alterations that eliminate the expression of either proteinase. 4 Elastolytic cysteine proteases, including cathepsins, also play a critical role in the development of aneurysm. 5 AAA is also considered an immune and inflammatory disease, and macrophages, lymphocytes, and mast cells participate in its development. 1 However, the role of complement, a main effector of immunity and inflammation, remains unclear.
Clinical Perspective on p 1346
The complement system consists of Ϸ30 soluble and membrane-bound proteins and is activated by different sequential activation cascades (the classic, alternative, and lectin pathways) either on the pathogens or in plasma. These pathways converge in 1 terminal cascade that leads to the formation of the membrane attack complex (MAC), a mac-romolecular pore capable of inserting itself into cell membranes and lysing heterologous cells and bacteria. To protect autologous cells from MAC-mediated attack, an array of complement regulators, including CD59, have evolved to restrict complement activation. CD59, a glycosylphosphatidyl inositol-linked membrane protein, strongly restricts MAC formation by binding to complement proteins C8 and C9 and preventing C9 incorporation and polymerization.
MAC is also an important mediator of cellular signals that trigger mitogenic effects. Insertion of the MAC allows the release of growth factors such as basic fibroblast growth factor and platelet-derived growth factor and cytokines such as interleukin-1 and monocyte chemoattractant protein-1, which autocrinally and paracrinically stimulate proliferation, inflammation, and thrombosis. 6, 7 In vitro studies indicate that sublytic MAC activates several cellular signaling pathways such as the PI3/Akt (serine/threonine) kinase pathway, 8, 9 the nuclear factor (NF)-B, and the activator protein-1 (AP-1). 10, 11 Extensive evidence from human and animal studies indicates a protective role of CD59 12, 13 and an atherogenic role of MAC in the pathogenesis of atherosclerosis. 14 However, only a few human studies (and no animal studies) have examined the role of MAC in the pathogenesis of aneurysm. 15, 16 Here, we investigate the role of CD59 and MAC in the pathogenesis of the AAA induced by angiotensin (Ang II) in ApoE Ϫ/Ϫ mice either deficient in mouse CD59a and mouse CD59b (mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ ; described previously 14, 17 ) or transgenically overexpressing human CD59 (hCD59) in endothelial and circulating cells (hCD59 ICAM-2ϩ/Ϫ /ApoE Ϫ/Ϫ ; described elsewhere 14, 18 ).
Methods
Animal studies were approved by the Harvard Medical School Institutional Animal Care and Use Committee.
Animal Models and AAA Production and Quantification
Both mCd59ab Ϫ/Ϫ and hCD59 ICAM-2ϩ/Ϫ mice were in C57BL/6 (B6) genetic background as described elsewhere. 17, 18 The hCD59 in hCD59 ICAM-2ϩ/Ϫ mice is selectively expressed in endothelial cells, macrophages, and platelets. 19 In these transgenic strains, overexpression of hCD59 is effective in providing additional protection against mouse complement. 18, 19 We crossed each of the 2 strains with ApoE Ϫ/Ϫ mice (B6 background, The Jackson Laboratory, Bar Harbor, Me) to produce mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ and hCD59 ICAM-2ϩ/Ϫ /ApoE Ϫ/Ϫ mice, respectively. The successful generation of these compound mice was determined by both polymerase chain reaction (PCR) methods (for genotyping as described in Figure  IA through IC in the online-only Data Supplement) and fluorescence-activated cell sorting analysis of mCd59a and mCd59b proteins in mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ erythrocytes (for confirming the physical absence of mCd59a and mCd59b) or hCD59 in the hCD59 ICAM-2ϩ/Ϫ /ApoE Ϫ/Ϫ platelets (for confirming the overexpression of hCD59; data not shown).
It has been established that the low dose of Ang II used is associated with a significant (30% to 40%) increase in blood pressure. 20 The high blood pressure may participate in the pathogenesis of Ang II-induced AAA, 20 and Ang II may contribute to medial macrophage accumulation associated with elastin degradation. 21 Because in hyperlipidemic mice the propensity for the development of AAA is much more common in males than females (as is the case in humans), we selected males as experimental animals. To induce AAA, 3-month-old male mice were infused with 1000 ng⅐kg Ϫ1 ⅐min Ϫ1 Ang II (Calbiochem, San Diego, Calif) subcutaneously delivered by Alzet model 2004 osmotic minipumps (DURECT Corp, Cupertino, Calif) as described previously 22 and simultaneously fed a high-fat diet (C12108; Research Diets Inc, New Brunswick, NJ) for 1 month. 23, 24 After fasting the mice overnight, we euthanized them by CO 2 asphyxiation, drew blood by heart puncture, and stored the sera at Ϫ80°C. The aorta was viewed with a dissection microscope. The per-adventitial tissue was carefully removed from the aortic wall as described previously. 22 The maximal diameter of each aneurysm was measured with a digital caliper. The segment of the aorta from the aortic arch to renal artery was weighed, and one half of the AAA lesion was preserved with optimal cutting temperature compound and stored at Ϫ80°C (for immunoassays). The other half was stored at Ϫ80°C for extraction of proteins for Western analysis and gelatin zymography. For the detailed procedures of immunofluorescence, histology, and gelatin zymography, please see the online-only Data Supplement.
Reporter Assays
The plasmids of pGL2-AP-1-Luc and pGL2-NF-B-Luc luciferase reporters (generous gifts from Zhu and Rosenfeld) were generated by cloning AP-1 and NF-B response elements cloned into the pGL2-Luc plasmid, respectively. 25 Mouse endothelial cells (2ϫ10 4 each well) were transfected by Lipofectamine 2000 (Invitrogen, Carlsbad, Calif) with pGL2-AP-1-Luc or pGL2-NF-B-Luc luciferase reporter plasmid (see details in the online-only Data Supplement).
RNA Interference
Endothelial cells (2.5ϫ10 5 per well, 6-well plates) were transiently transfected with Lipofectamine RNAiMA X (Invitrogen) 5 L in each well with 50 nmol/L mouse p50, mouse c-jun, and siGENOME nontargeting small interfering RNA (siRNA) Pool (Dharmacon, Lafayette, Colo). The sequences of these siRNA are listed in Table  I in the online-only Data Supplement. After 36 hours of incubation, cells were stimulated with MAC (C5b6: 24 g/mL and ϩ for C7, C8 or C9: 24 g/mL) for an additional 12 hours, and proteins or RNA was isolated and subjected to Western blot and zymography or to real-time reverse-transcription PCR analysis, respectively.
Quantitative Real-Time PCR Analysis
Total RNA was isolated from the cultured mouse endothelial cells C166 (ATCC) treated with C5b-9 assembled and siRNA for 12 hours with Trizol reagent (Invitrogen). Real-time PCR was performed with SYBR Green in a real-time PCR machine (iCycler; Bio-Rad Laboratories, Hercules, Calif). We used the primers listed in Table II in the online-only Data Supplement for detecting p50, c-Jun, MMP2, and MMP9 RNA levels. To normalize expression data, 18s rRNA was used as an internal control gene.
Western Blotting
The proteins were isolated from the mouse AAA or mouse endothelial cells treated with MAC. Primary antibodies for Western blotting, including rabbit p-p65 antibody (Cell Signaling Technology, Danvers, Mass), rabbit p-IKK-␣/␤ antibody (Cell Signaling), rabbit p-c-Jun antibody (Cell Signaling), rabbit p-c-Fos antibody (Abcam, Cambridge, Mass), rabbit c-Jun antibody (Santa Cruz Biotechnology, Inc, Santa Cruz, calif), rabbit p65 monoclonal antibody (Cell Signaling), rabbit IKK-␣/␤ antibody (Santa Cruz Biotechnology), rabbit p50 antibody (Santa Cruz Biotechnology), rabbit c-Fos monoclonal antibody (Cell Signaling), and mouse anti-mouse ␤-actin antibody (Santa Cruz Biotechnology, Inc), which were diluted in blocking buffer, were incubated with the membranes. The final concentrations for these antibodies are listed in Table II in the online-only Data Supplement (see the online-only Data Supplement for details).
Statistical Analysis
Experimental results are shown as meanϮSEM. The comparisons between 2 or 3 groups were examined with a nonparametric Mann-Whitney test or nonparametric Kruskal-Wallis test, respec-tively. Details of real-time PCR analysis are given in Materials section in the online-only Data Supplement. The difference in mortality rate was analyzed by 2 test. All statistical tests with values of PϽ0.05 were considered significant.
Results

Protective Role of CD59 Against AAA Development
We used the ApoE Ϫ/Ϫ mice either deficient in mCd59a and mCd59b (mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ ) or overexpressing hCD59 in the endothelial cells, macrophages, and platelets (hCD59 ICAM-2ϩ/Ϫ /ApoE Ϫ/Ϫ ) to investigate the role of CD59 and MAC in the AAA. Here, we induced the AAA by the infusion of Ang II to these models to study the role of CD59 in the pathogenesis of AAA. mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ mice developed significantly more severe AAA assessed by diameter and weight of the aneurysms ( Figure 1A through 1C and Figure II in the online-only Data Supplement) and had a higher mortality rate than ApoE Ϫ/Ϫ mice ( Figure 1D ). In contrast, the mice transgenic for hCD59 in the endothelial and hematopoietic cells (hCD59 ICAM-2ϩ/Ϫ /ApoE Ϫ/Ϫ ) developed significantly less severe AAA than ApoE Ϫ/Ϫ mice ( Figure 1A  through 1D ). The incidence rates of the development of AAA in mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ , ApoE Ϫ/Ϫ , and hCD59 ICAM-2ϩ/Ϫ / ApoE Ϫ/Ϫ mice were 100%, 75%, and 75% among the surviving mice, respectively. In addition, mCd59ab Ϫ/Ϫ / ApoE Ϫ/Ϫ mice had much lower collagen content in the aortas of the AAA than ApoE Ϫ/Ϫ mice, whereas hCD59 ICAM-2ϩ/Ϫ /ApoE Ϫ/Ϫ mice had higher collagen content than ApoE Ϫ/Ϫ mice ( Figure 1E and Figure IIIA in the online-only Data Supplement). An additional difference between mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ aneurysms and the others was that mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ mice had more disrupted elastic lamellae than other 2 group mice ( Figure 1F ). In addition, the cholesterol and triglyceride levels among these groups were not significantly different ( Figure IIIB and IIIC in the online-only Data Supplement). The systolic blood pressure among the 3 different groups of mice after Ang II infusion was not significantly different ( Figure IV in the online-only Data Supplement), which indicates that either CD59 deficiency or hCD59 overexpression in ApoE Ϫ/Ϫ background mice does not change blood pressure response to Ang II and high-fat diet treatments compared with the ApoE Ϫ/Ϫ mice. Together, these results suggest that CD59 protects the mice against AAA development.
MAC Deposition in the AAA Lesions
CD59 is well known as a key inhibitor of MAC formation. To further investigate the underlying mechanisms by which CD59 protects against the development of AAA, we analyzed MAC deposition in AAA lesions. Staining of the aneurysm sections with anti-C9-specific antibodies revealed that mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ mice had significantly more extensive deposits of C9 than ApoE Ϫ/Ϫ mice and that ApoE Ϫ/Ϫ mice has significantly more deposits of C9 than hCD59 ICAM-2ϩ/Ϫ / ApoE Ϫ/Ϫ mice (Figure 2A and Figure VA in the online-only Data Supplement). Analysis of adjacent sections with hematoxylin and eosin staining demonstrated that the C9 deposition was in both thrombi ( Figure 2B1 and 2C1) and granulation tissue ( Figure 2B2 , 2B3, 2C2, and 2C3). Immunofluorescence staining of AAA showed that mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ mice had significantly more macrophages than ApoE Ϫ/Ϫ mice, which in turn had significantly more macrophage cells than hCD59 ICAM-2ϩ/Ϫ /ApoE Ϫ/Ϫ mice ( Figure 2D and Figure VB in the online-only Data Supplement). Together, these results are consistent with a pathogenic role of MAC in the development of AAA in our experimental mice.
MAC Upregulates MMP2 and MMP9 Activities
MMP2 and MMP9 play essential roles in the pathogenesis of AAA. Inhibition of and deficiency for MMP2 and MMP9 have been shown to attenuate AAA development in humans and animals. 26 Increased MMP2 and MMP9 activities contribute to degradation of elastin and type IV collagen in tissues, including arteries, 27 which could explain the greater disruption in elastic lamellae and the lower collagen content in AAA lesions of mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ mice ( Figure 1F ). For these reasons, we assessed the MMP2 and MMP9 activities in AAA lesions by gelatin zymography. 28 AAA aortic extracts from mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ mice exhibited significantly higher MMP2 and MMP9 activities, whereas extracts from hCD59 ICAM-2ϩ/Ϫ /ApoE Ϫ/Ϫ mice showed lower activities than ApoE Ϫ/Ϫ mice ( Figure 3A and 3B) .
The fact that MAC deposition and MMP activity correlated with the severity of AAA in our animal models prompted us to investigate whether MAC upregulates MMP2 and MMP9 activities in vitro. MAC treatment increased MMP2 and MMP9 activities in the mouse vascular smooth muscle, endothelial, and macrophage cells compared with C5b6 alone, which does not lead to MAC assembly, or PBS treatment ( Figure 4A through 4C) . These results indicate that MAC may stimulate the cells and increase MMP2 and MMP9 activities, which may contribute to the development of accelerated AAA lesions in mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ mice.
MAC Upregulates MMP2 and MMP9 Activities Through AP-1 and NF-B Signaling Pathways
It has been demonstrated that sublytic MAC induces increased activity of c-Jun NH2-terminal kinase (JNK1) in many cells (including endothelial cells and smooth muscle cells 29 ) and activation of NF-B and AP-1. 10, 11 To assess the effect of MAC on these signaling pathways, we analyzed the expression of the p-c-Jun, c-Fos (AP-1 components), p65 (an NF-B component), and IKK-␣/␤ (an NF-B regulator) in the AAA lesions of 3 groups of mice or in the endothelial cell cultures challenged by MAC in vitro. Western blot assay Most of lumen (*) has been occluded by a thrombus (T) shown in high magnification (ϫ20) in C1. It is within the thrombus that C9 staining (A1) is most intense. A2, Much of the wall of the aorta has been thickened by proliferative granulation tissue (G), fibroblasts, and collagen; some inflammatory cells and edema fluid are shown in higher magnification (ϫ20) in C2. A3, Much of the wall has been thickened by granulation tissue, which in this case is less edematous than in C3, shown in higher magnification (ϫ20). D, CD68 for the detection of macrophage content in lesion areas (see Figure VB in the online-only Data Supplement for quantitative analysis of the result).
revealed that the AAA in mCd59ab Ϫ/Ϫ ApoE Ϫ/Ϫ mice had significantly higher levels of p-c-Jun, p-c-Fos, p-IKK-␣/␤, and p-p65, whereas AAA from hCD59 ICAM-2ϩ/Ϫ /ApoE Ϫ/Ϫ mice had significantly lower levels than ApoE Ϫ/Ϫ mice ( Figure 5A ). In contrast, total levels of c-Jun, IKK-␣/␤, and p65 did not differ among the 3 groups ( Figure VIA in the online-only Data Supplement). This indicates that the activation of these signaling pathways may play a critical role in the development of AAA in our models. Consistent with these results, we also demonstrated that MAC assembly in mouse endothelial cells directly induced significantly higher levels of p-c-Jun, p-c-Fos, p-IKK-␣/␤, and p-p65 than C5b6 alone in vitro ( Figure 5B and Figure VIB in the online-only Data Supplement), confirming the previous finding that MAC activates these signaling pathways in vitro, 11, 30, 31 These results, together with the facts that AP-1 is composed of c-Jun and c-Fos and that p65 is a major component of NF-B, 32, 33 indicate that MAC is capable of triggering signaling pathways upstream of AP-1 and NF-B.
To directly evaluate whether MAC upregulates the activity of AP-1 or NF-B, we used a firefly luciferase reporter gene assay to measure their transcriptional activity on MAC assembly on endothelial cells. The reporter gene activity is directly under the control of AP-1 and NF-B response elements. As shown in Figure 5C , MAC induced significantly higher levels of AP-1 and NF-B transcriptional activity than C5b6 alone or PBS treatment ( Figure 5C ). These results indicate that MAC assembly on the cells transcriptionally upregulates AP-1 and NF-B.
Furthermore, to investigate whether AP-1 and NF-B signaling pathway activations are involved in the upregulation of MMP2 and MMP9 mediated by MAC in vitro, we used RNA interference against c-Jun and p50, another component of NF-B, to suppress these pathways. The upregulation of MMP2 and MMP9 mRNA and proteins mediated by MAC was attenuated by both p50 (Figure 5D ) and c-Jun RNAi ( Figure 5E ). RNAi efficacy was validated at the level of both mRNA and protein ( Figure VIIA and VIIB in the online-only Data Supplement). Together, these results suggest that MAC-activated c-Jun and NF-B signaling pathways participate in the upregulation of MMP2 and MMP9, which may in turn contribute to the pathogenesis of AAA in our animal models.
Discussion
The results reported here provide strong support for a protective role of CD59 against the development of AAA and indicate that MAC may indeed play a critical role in the pathogenesis of AAA. The role of complement and MAC in AAA has only been suggested in human studies and has not extensively been studied in experimental models. Patients with vasospasm showed a 2-fold increase in plasma C3d levels when the spasm occurred, whereas no significant changes in C3d concentration could be detected in aneurysm patients without spasm or in patients with hematoma unrelated to aneurysm rupture. 34 Specific gene array analysis revealed that increased gene expression was associated with proteinase, reactive oxygen species, growth factors, chemokines, complement, adhesion molecules, and apoptosis in both the intima and the media of aneurysmal walls. 35 Moreover, immunohistochemistry studies of human saccular cerebral artery aneurysm demonstrated that MAC localized consistently in a decellularized layer in the outer wall and were found in all saccular cerebral artery aneurysm samples. The percentage of MAC-positive area relative to the total saccular cerebral artery aneurysm wall surface area was greater in ruptured than in unruptured saccular cerebral artery aneurysms. 16 Moreover, a recent study demonstrates that C3a and C5a play a critical role in the development of elastaseinduced AAA. 36 Together, these data suggest that complement activation and MAC formation are involved in aneurysm wall degeneration and rupture. We used genetic strategies to investigate the role of MAC in AAA. We identified a critical role of CD59 in protecting against AAA and demonstrated that MAC may play a critical pathogenic role in AAA. It is notable that the deficiency of CD59 results in mild complement-mediated hemolytic anemia and platelet activation. 17, 37, 38 The hCD59 in hCD59 ICAM-2 is expressed not only in endothelial 18 but also in circulating cells, including macrophages (see Figure VIII in the online-only Data Supplement) and platelets, 14 because the hCD59 transgene in hCD59 ICAM-2 mice is under the control of intracellular adhesion molecule-II. 19 The protective effects in hCD59 ICAM-2ϩ/Ϫ / ApoE Ϫ/Ϫ mice against the development of AAA are contributed by the expression of hCD59 in these cells. However, the cellular mechanism of the hCD59 protective role remains unclear. In addition, CD59 also has a complementindependent function in regulating NK-, B-, and T-cell activities, 39, 40 which may contribute to the AAA. Thus, the mechanisms underlying CD59 complement-independent function and MAC-mediated cellular dysfunction in the development of AAA require further investigation.
Cellular response to MAC formation can be classified into 2 groups (lytic and sublytic) along a response continuum. Lytic MAC formation results in colloidoosmotic swelling and lysis of the target. 41 Sublytic MAC formation results in the release of growth factors and cytokines, activation of cellular signaling, and/or reprogramming of gene expression. When the pore opens transiently, it can generate significant changes in membrane permeability and internal composition of autologous cells without compromising their viability. Thus, lytic MAC can induce lethal colloidoosmotic swelling in cells such as Gram-negative bacteria and heterologous erythrocytes. On the other hand, sublytic MAC mediates nonlethal physiological and/or pathological responses and activates many signaling pathways in autologous cells. 7 These cellular signaling pathways include elevated Ca 2ϩ via Ca 2ϩ influx through transient pore in cells, which partially activates protein kinase C and other cellular signaling pathways 42 ; G protein-coupled activation of the Ras, Raf-1, MEK, and ERK-1 pathways and increased activities of ERK-1, JNK1, and p38 mitogen-activated protein kinase in many cells, including endothelial cells and smooth muscle cells 30 ; activation of the PI3/Akt kinase pathway 9, 30 ; activation of the NF-B and AP-1 signaling pathways 11, 31 ; and activation of the JAK1/STAT3 pathway. 29 Among these signaling pathways, c-Jun and NF-B activation pathways have been demonstrated to play a critical role in AAA in vivo. 43, 44 Here, we demonstrated that AAA lesions in mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ mice had significantly higher and in hCD59 ICAM-2ϩ/Ϫ /ApoE Ϫ/Ϫ mice had significantly lower levels of p-c-Jun, p-c-Fos, p-IKK-␣/␤, and p-65 than those in ApoE Ϫ/Ϫ mice. The fact that the activation of AP-1 and NF-B signaling pathways positively correlated with the severity of the AAA among our experimental mice confirms some of these findings and further suggests that MAC is an important signaling activator that may play a critical role in the pathogenesis of chronic inflammatory diseases such as AAA.
Whether MAC induces upregulation of MMP2 and MMP9 and which MAC-triggered signaling pathways are involved in the pathogenesis of AAA have not been examined until now. Here, we demonstrate that MAC induces the production of MMP2 and MMP9, that MMP2 and MMP9 activities were correlated with the severity of AAA, and that MAC-induced upregulation of MMP2 and MMP9 activities is related to the activation of AP-1 and NF-B signaling pathways. Together, these results shed light on the important pathogenic role of MAC in the AAA and point toward the molecular mechanism of MAC-activated signaling pathways in the development of aneurysm and atherosclerosis.
Extensive evidence indicates that MMP2 and MMP9 play essential roles in the pathogenesis of AAA, 26 and macrophages are the primary source of MMP-9 production in human and mouse AAA tissues. 45, 46 In the AAA lesions of mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ mice, the macrophage content is significantly increased, as shown in Figure 2D and Figure VB in the online-only Data Supplement. This is consistent with the severity of AAA and higher levels of MMP2 and MMP9 in these lesions. We previously demonstrated that MAC induced endothelial dysfunction in mCd59ab Ϫ/Ϫ /ApoE Ϫ/Ϫ mice, which contributes the atherogenesis. 14 MAC also mediates endothelial cell apoptosis in vitro. 47 Furthermore, we document that the supernatant obtained from MAC-treated endothelial cells triggers the migration of both MAC-treated and non-MAC-treated macrophage in vitro ( Figure IXA in the online-only Data Supplement). The increase in macrophage migration may result from the release of growth factors and cytokines induced by sublytic MAC assembly in endothelial cells, as we reported previously. 6, 7 Of note, the deficiency of Table II in the online-only Data Supplement. Fold changes in the MMP activities or levels with specific siRNAs treatment compared with these treated with control siRNA. The data from the independent experiments (n) are displayed by box plots. *PϽ0.05 vs control siRNA.
CD59 in mice does not result in a decreased number of monocytes ( Figure IXB in the online-only Data Supplement). Together, these findings lead us to conclude that increased MMP expression in the aorta in AAA could be caused by increased macrophage infiltration, upregulation by increased MAC tissue levels, or some combination of these 2 mechanisms.
